Your browser doesn't support javascript.
loading
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study.
Schultheis, B; Reuter, D; Ebert, M P; Siveke, J; Kerkhoff, A; Berdel, W E; Hofheinz, R; Behringer, D M; Schmidt, W E; Goker, E; De Dosso, S; Kneba, M; Yalcin, S; Overkamp, F; Schlegel, F; Dommach, M; Rohrberg, R; Steinmetz, T; Bulitta, M; Strumberg, D.
Affiliation
  • Schultheis B; Department of Hematology/Oncology, University Bochum, Marien Hospital Herne, Herne;. Electronic address: beate.schultheis@elisabethgruppe.de.
  • Reuter D; Oncoscience AG, Wedel (recently Schenefeld).
  • Ebert MP; Klinikum Rechts der Isar TU München, München.
  • Siveke J; Klinikum Rechts der Isar TU München, München.
  • Kerkhoff A; University Hospital Münster, Münster.
  • Berdel WE; University Hospital Münster, Münster.
  • Hofheinz R; Department of Hematology and Medical Oncology, University Medical Center Mannheim, Mannheim.
  • Behringer DM; Augusta-Kranken-Anstalt, Bochum.
  • Schmidt WE; St. Josef Hospital, Med. Klinik I, Bochum, Germany.
  • Goker E; Ege University Medical School, Izmir, Turkey.
  • De Dosso S; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Kneba M; Department of Medicine, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Yalcin S; Hacettepe University Hospital, Ankara, Turkey.
  • Overkamp F; Medical Practice for Oncology and Hematology, Recklinghausen.
  • Schlegel F; St. Antonius Hospital, Eschweiler.
  • Dommach M; Sana-Kliniken, Medizinisches Versorgungszentrum Onkologie, Düsseldorf.
  • Rohrberg R; Gemeinschaftspraxis und Tagesklinik fuer Haematologie, Onkologie und Gastroenterologie, Halle.
  • Steinmetz T; Group Practice Hematology/Oncology Cologne, Cologne.
  • Bulitta M; CRM Biometrics GmbH, Rheinbach, Germany.
  • Strumberg D; Department of Hematology/Oncology, University Bochum, Marien Hospital Herne, Herne.
Ann Oncol ; 28(10): 2429-2435, 2017 Oct 01.
Article in En | MEDLINE | ID: mdl-28961832
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Proto-Oncogene Proteins p21(ras) / Deoxycytidine Type of study: Clinical_trials / Guideline Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Proto-Oncogene Proteins p21(ras) / Deoxycytidine Type of study: Clinical_trials / Guideline Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article